Johnson & Johnson's Single-Dose Covid-19 Vaccine Is 66?fective In Global Trial, However Has Lower Effectiveness Against South African Variant thumbnail

Updated Jan 29, 2021, 10: 27 am ESTTopline Johnson & Johnson’s single-dose Covid-19 vaccine has shown 66?ficiency in preventing moderate and extreme illness, the company said in a https://www.jnj.com/johnson-johnson-announces-single-shot-janssen-covid-19- vaccine-candidate-met-primary-endpoints-in-interim-analysis-of-its-phase-3-ensemble-trial” target=” _ blank” class=” color-link” title=” https://www.jnj.com/johnson-johnson-announces-single-shot-janssen-covid-19- vaccine-candidate-met-primary-endpoints-in-interim-analysis-of-its-phase-3-ensemble-trial” aria-label=” press release” > press release on Friday, noting that the general number was dragged down by the 57?ficacy rate in South Africa which is seeing …
Learn More

By Admin